159 related articles for article (PubMed ID: 30196732)
1. Low molecular weight chitosan-based conjugates for efficient Rhein oral delivery: synthesis, characterization, and pharmacokinetics.
Luo J; Sun J; Luo X; Wei Y; Zheng H; Mu C; Yao W
Drug Dev Ind Pharm; 2019 Jan; 45(1):96-104. PubMed ID: 30196732
[TBL] [Abstract][Full Text] [Related]
2. A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan.
Lee E; Lee J; Jon S
Bioconjug Chem; 2010 Oct; 21(10):1720-3. PubMed ID: 20849099
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, screening and nanocrystals preparation of rhein amide derivatives.
Chen L; Zhang J; Rong J; Liu Y; Zhao J; Cui Q; Wang X; Liang X; Pan H; Liu H
J Microencapsul; 2018 Jun; 35(4):313-326. PubMed ID: 29683357
[TBL] [Abstract][Full Text] [Related]
4. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
Ahn S; Lee IH; Lee E; Kim H; Kim YC; Jon S
J Control Release; 2013 Sep; 170(2):226-32. PubMed ID: 23747732
[TBL] [Abstract][Full Text] [Related]
5. A novel β-cyclodextrin-rhein conjugate for improving the water solubility and bioavailability of rhein.
Wang J; Qian Y; Qian C; Shi F; Yao J; Bi X; Chen Z
Carbohydr Res; 2020 Apr; 490():107958. PubMed ID: 32120022
[TBL] [Abstract][Full Text] [Related]
6. Deoxycholic acid-functionalised nanoparticles for oral delivery of rhein.
Yao W; Xu Z; Sun J; Luo J; Wei Y; Zou J
Eur J Pharm Sci; 2021 Apr; 159():105713. PubMed ID: 33453389
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokinetics.
Wei Y; Luo X; Guan J; Ma J; Zhong Y; Luo J; Li F
Drug Dev Ind Pharm; 2017 Nov; 43(11):1885-1891. PubMed ID: 28692315
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery.
Feng H; Zhu Y; Fu Z; Li D
Chem Biol Drug Des; 2017 Nov; 90(5):867-872. PubMed ID: 28432812
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.
Allam AN; Hamdallah SI; Abdallah OY
Int J Nanomedicine; 2017; 12():4733-4745. PubMed ID: 28740381
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel.
Wang X; Guo Y; Qiu L; Wang X; Li T; Han L; Ouyang H; Xu W; Chu K
Carbohydr Polym; 2019 Feb; 206():121-131. PubMed ID: 30553305
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Characterization of an Oral Norethindrone Sustained Release/Controlled Release Nanoparticles Formulation Based on Chitosan.
Altaani BM; Al-Nimry SS; Haddad RH; Abu-Dahab R
AAPS PharmSciTech; 2019 Jan; 20(2):54. PubMed ID: 30617756
[TBL] [Abstract][Full Text] [Related]
13. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
[TBL] [Abstract][Full Text] [Related]
15. Reduced system exposures of total rhein and baicalin after combinatory oral administration of rhein, baicalin and berberine to beagle dogs and rats.
Wang Z; Hu H; Chen F; Lan K; Wang A
J Ethnopharmacol; 2013 Jan; 145(2):442-9. PubMed ID: 23159470
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic behavior of argirein, derived from rhein, is characterized as slow release and prolonged T₁/₂ of rhein in rats.
Cong XD; Fu PR; Dai DZ; Zhang Y; Dai Y
Eur J Pharm Sci; 2012 Aug; 46(5):468-74. PubMed ID: 22521276
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery.
Yuan Z; Gu X
Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633
[TBL] [Abstract][Full Text] [Related]
18. Preparation of Ginkgolide Solid Dispersions with Low-Molecular-Weight Chitosan and Assessment of their Protective Effect on Isoproterenol- Induced Myocardial Injury.
Zhang L; Xia Z; Liu B; Cui L; Ding W; Liu D
Curr Drug Deliv; 2020; 17(8):711-719. PubMed ID: 32621716
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic study on the mechanism of toxicity attenuation of rhubarb total free anthraquinone oral colon-specific drug delivery system.
Zhang L; Chang JH; Zhang BQ; Liu XG; Liu P; Xue HF; Liu LY; Fu Q; Zhu M; Liu CZ
Fitoterapia; 2015 Jul; 104():86-96. PubMed ID: 26036751
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan.
Liu QY; Zhang ZH; Jin X; Jiang YR; Jia XB
J Pharm Pharmacol; 2013 Jun; 65(6):839-46. PubMed ID: 23647677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
